Highbridge Capital Management, LLC 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 5:06 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | Highbridge Capital Management, LLC | 3,633,333 9.200% | 3,633,333 (New Position) | Filing |